Does RISANKIZUMAB-RZAA Cause Hypoacusis? 131 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Hypoacusis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
131
Reports of Hypoacusis with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
0
Deaths
22
Hospitalizations
How Dangerous Is Hypoacusis From RISANKIZUMAB-RZAA?
Of the 131 reports, 22 (16.8%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Hypoacusis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Hypoacusis?
SACUBITRIL\VALSARTAN (2,345)
TOFACITINIB (1,535)
INSULIN GLARGINE (1,406)
APIXABAN (1,249)
PREGABALIN (1,152)
ETANERCEPT (1,109)
INSULIN LISPRO (1,100)
ADALIMUMAB (948)
LENALIDOMIDE (938)
PALBOCICLIB (890)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Hypoacusis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA